Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Spokane
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Spokane, WA

Studies commonly pay $75 to $4,500 per completed study

291 clinical trials are currently recruiting participants within 30 miles of Spokane. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

291studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Spokane right now

Top 25 of 291 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Spokane Eye Clinical Research — Spokane, Washington (0.5 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Medical Oncology Associates, PS (dba Summit Cancer Centers) ( Site 0010) — Spokane, Washington (0.5 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Cystic Fibrosis N/A Observational 400 participants sought
Providence Medical Group, Cystic Fibrosis Clinic — Spokane, Washington (0.5 mi) · Sponsor: Nicole Hamblett
See eligibility & contact on ClinicalTrials.gov (NCT06504589)

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

Actinic Keratosis Phase 3 Interventional 160 participants sought
Premier Clinical Research — Spokane, Washington (0.5 mi) · Sponsor: Sun Pharmaceutical Industries, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07144345)

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,524 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07200830)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Geographic Atrophy, Macular Degeneration Phase 2 Interventional 274 participants sought
Spokane Eye Clinical Research — Spokane, Washington (0.5 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06635148)

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Non-Muscle Invasive Bladder Neoplasms N/A Observational 150 participants sought
Spokane Urology — Spokane, Washington (0.5 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07309445)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05099003)

Developing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery

Alcohol Use Disorder (AUD) N/A Observational 30 participants sought
Washington State University Research Clinic — Spokane, Washington (0.5 mi) · Sponsor: Washington State University
See eligibility & contact on ClinicalTrials.gov (NCT07052318)

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Alcohol Use Disorder (AUD), Nicotine Use Disorder Phase 2 Interventional 205 participants sought
Washington State University — Spokane, Washington (0.5 mi) · Sponsor: Washington State University
See eligibility & contact on ClinicalTrials.gov (NCT05181891)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05675410)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 Phase 3 Interventional 486 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07097142)

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Phase 3 Interventional 466 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07321652)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Macular Degeneration, Age-Related Macular Degeneration Phase 2, Phase 3 Interventional 960 participants sought
Spokane Eye Clinical Research (Site 075) — Spokane, Washington (0.5 mi) · Sponsor: EyeBiotech Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07440225)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
MultiCare Deaconess Cancer and Blood Specialty Center - Downtown — Spokane, Washington (0.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Basal Ganglia Germinoma, Diabetes Insipidus Phase 2 Interventional 240 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT06368817)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Spokane, Washington (0.5 mi) · Sponsor: Medtronic
See eligibility & contact on ClinicalTrials.gov (NCT00271180)
Actively enrolling

Studies you may be able to join near Spokane

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Spokane

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Inland Northwest Research

★ 5.0
610 S Sherman St Ste 208, Spokane, WA 99202
(509) 960-2818

Premier Clinical Research

★ 5.0
324 S Sherman St, Spokane, WA 99202
(509) 343-3710

Providence Medical Research Center

★ 5.0
105 W 8th Ave Ste 250E, Spokane, WA 99204
(509) 474-4345
"I dont know will see after my appointment today"
— Terry A, 5★

Citta Clinical Research

251 E 5th Ave Ste a, Spokane, WA 99202
(509) 816-1819

Principle Research Solutions

510 S Cowley St, Spokane, WA 99202
(509) 474-1107

WSU Spokane Center for Clinical Research and Simulation (CCRS)

410 North Sherman Street, Spokane, WA 99202
(509) 358-7500

WSU APPL & PRISM Research Clinics

★ 5.0
225 E 3rd Ave, Spokane, WA 99202
(509) 638-2376
"The people who work there are so caring & friendly.<br>I always look forward to visiting them."
— Michael K., 5★

Strategic Research Associates

★ 3.8
29 W Pacific Ave, Spokane, WA 99201
(888) 554-6960
"I have received texts occasionally for the last 10 years that I’m “qualified” for one of their surveys/programs. I’ve filled out 20+ questionnaires t…"
— Morgan Ireland, 1★

Velocity Clinical Research

★ 5.0
9921 N Nevada St Ste 200, Spokane, WA 99218
(509) 505-6227
"The staff is always awesome as well as my experience with the clinical trials. Down 26 pounds in just a few months. Not been this weight since just …"
— Rebecca Williams, 5★

Clinical trials in Spokane: what's recruiting

The Spokane area currently has 291 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Spokane, the most active research areas are:

  • Cancer & Oncology16 studies
  • Heart & Vascular3 studies
  • Liver & Kidney1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Spokane, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Spokane

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Spokane participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Spokane pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Spokane?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Spokane safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Spokane, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Spokane?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Spokane.

Paid clinical trials near Spokane

Other metros within reach

Kennewick, WA55 Nampa, ID252 Boise, ID252 Bellevue, WA1,520 Marysville, WA200 Seattle, WA1,510 Tacoma, WA1,464 Bremerton, WA1,481

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Spokane Bladder Issues Due To Spinal Cord Injury in Spokane All conditions

More of WA

Bellevue1,520 Seattle1,510 Bremerton1,481 Tacoma1,464 Vancouver1,021 Olympia234 Marysville200 Kennewick55

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts